Pharma News

Before surgeons remove the pancreas from patients with severe, painful chronic pancreatitis, they first harvest insulin-producing tissue clusters, called islets, and transplant them into the vasculature of the liver. The goal of the transplant is to preserve a patient’s ability to control their own blood-glucose levels without insulin injections.

A new DNA search tool, akin to a Google for genetic material, shows great potential, as reported by its Swiss creators. In a groundbreaking study, they managed to index 10 percent of the globes known DNA, RNA, and protein sequences, suggesting that this approach could feasibly expand to encompass the entirety of biological sequence data.

Torrent Pharmaceuticals has entered into a non-exclusive patent licensing agreement with Takeda to commercialize Vonoprazan in India.

TREX1 is a gene that is supposed to direct the maintenance of the entire body DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a deadly rare disease called retinal vasculopathy with cerebral leukoencephalopathy

Pre-clinical tests showed that insulin with the peptide effectively reaches the bloodstream whereas without the peptide, insulin remains stuck in the inside lining of the mouth.

Antibody therapies called bispecific T cell engagers have emerged as effective treatments for some blood cancers but have been more difficult to develop for solid tumors. While clinically successful, first-generation BTEs suffer a short half-life.

A new study by Florida Atlantic Universitys Schmidt College of Medicine has uncovered a disturbing trend in drug-related infant deaths in the United States from 2018 to 2022.

Tumour protein P53 (TP53) plays an important role in suppressing the growth of tumours. Mutations in the gene for TP53 can have a disastrous effect, hampering the body's ability to fight tumours and even encouraging their growth. Because these are the most common mutations in cancers, TP53 has long been an interesting therapeutic target. However, efforts to destroy the mutant protein have been hampered by the difficulty of finding a way to bind to it.